Learning Objectives:

  1. Review the rationale, data and recommendations for germline pharmacogenomic testing in oncology patients
  2. Discuss methods for ongoing and planned analysis to assess the potential impact of pharmacogenomic testing in oncology at the University of Chicago
  3. Propose a design for a randomized controlled clinical trial examining the impact of pharmacogenomic testing in oncology patients at the University of Chicago

and

  1. Review current mechanisms of immunotherapy
  2. Discuss additional opportunities to enhance the anti-tumor immune response

                               3. Discuss new candidate immuno-regulatory molecules

Session date: 
Monday, October 28, 2019 - 12:00pm to 1:00pm
Speaker Name: 
Natalie M. Reizine, MD and Sherin J. Rouhani, MD, PhD
Location: 
UCMC
900 East 57th Street
KCBD Auditorium 1103
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.